IMMUNITYBIO, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
IMMUNITYBIO, INC. (IBRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 167.44 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 167.44M shares, a 1.41% increase year-over-year.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 167.25M shares, a 23.18% increase year-over-year.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 193.01M shares, a 1.13% decline year-over-year.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 165.10M shares, a 20.05% decline year-over-year.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 191.81M shares, a 65.29% increase from fiscal 2024.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 116.04M shares, a 47.05% decline from fiscal 2023.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 219.17M shares, a 200.98% increase from fiscal 2022.
- IMMUNITYBIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 72.82M shares, a 493.04% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 167.44M shares 10-Q · filed 2026-08-04 | 167.44M shares 10-Q · filed 2026-08-04 | ||||||
| 2026-03-31 | 167.25M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 191.81M shares 10-K · filed 2026-02-23 | |||||||
| 2025-09-30 | 193.01M shares 10-Q · filed 2025-11-05 | 193.01M shares 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | 165.10M shares 10-Q · filed 2026-08-04 | 165.10M shares 10-Q · filed 2026-08-04 | ||||||
| 2025-03-31 | 135.78M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 116.04M shares 10-K · filed 2026-02-23 | |||||||
| 2024-09-30 | 195.21M shares 10-Q · filed 2025-11-05 | 195.21M shares 10-Q · filed 2025-11-05 | ||||||
| 2024-06-30 | 206.50M shares 10-Q · filed 2025-08-05 | 206.50M shares 10-Q · filed 2025-08-05 | 206.50M shares 10-Q · filed 2024-08-12 | |||||
| 2024-03-31 | 219.63M shares 10-Q · filed 2025-05-12 | 219.63M shares 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | 219.17M shares 10-K · filed 2026-02-23 | 219.17M shares 10-K · filed 2024-03-19 | ||||||
| 2023-09-30 | 174.35M shares 10-Q · filed 2024-11-12 | 174.35M shares 10-Q · filed 2024-11-12 | 174.35M shares 10-Q · filed 2023-11-09 | |||||
| 2023-06-30 | 101.17M shares 10-Q · filed 2024-08-12 | |||||||
| 2023-03-31 | 86.88M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 72.82M shares 10-K · filed 2025-03-03 | 26.54M shares 10-K · filed 2023-03-01 | ||||||
| 2022-09-30 | 73.61M shares 10-Q · filed 2023-11-09 | 17.93M shares 10-Q · filed 2022-11-09 | ||||||
| 2022-06-30 | 17.95M shares 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | 16.61M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 12.28M shares 10-K · filed 2024-03-19 | |||||||
| 2021-09-30 | 12.91M shares 10-Q · filed 2022-11-09 | |||||||
| 2021-06-30 | 13.41M shares 10-Q · filed 2022-08-08 | |||||||
| 2021-03-31 | 14.25M shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 7.10M shares 10-K · filed 2023-03-01 | 3.98M shares 10-K · filed 2021-03-04 | ||||||
| 2020-09-30 | 7.34M shares 10-Q · filed 2021-11-12 | 4.13M shares 10-Q · filed 2020-11-09 | ||||||
| 2020-06-30 | 8.31M shares 10-Q · filed 2021-08-12 | 5.10M shares 10-Q · filed 2020-08-07 | ||||||
| 2020-03-31 | 8.82M shares 10-Q · filed 2021-05-14 | 5.61M shares 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | 8.87M shares 10-K · filed 2022-03-01 | 5.65M shares 10-K · filed 2020-03-25 | ||||||
| 2019-09-30 | 5.78M shares 10-Q · filed 2020-11-09 | |||||||
| 2019-06-30 | 5.89M shares 10-Q · filed 2020-08-07 | |||||||
| 2019-03-31 | 5.33M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 24.95M shares 10-K · filed 2021-03-04 | |||||||
| 2018-09-30 | 25.03M shares 10-Q · filed 2019-11-05 | |||||||
| 2018-06-30 | 24.28M shares 10-Q · filed 2019-08-06 | |||||||
| 2018-03-31 | 24.27M shares 10-Q · filed 2019-05-08 | |||||||
| 2017-12-31 | 24.30M shares 10-K · filed 2020-03-25 | |||||||
| 2017-09-30 | 24.50M shares 10-Q · filed 2018-11-07 | |||||||
| 2017-06-30 | 24.41M shares 10-Q · filed 2018-08-06 | |||||||
| 2017-03-31 | 24.52M shares 10-Q · filed 2018-05-07 | 24.52M shares 10-Q · filed 2017-05-08 | ||||||
| 2016-12-31 | 24.89M shares 10-K · filed 2019-03-13 | 24.89M shares 10-K · filed 2017-03-15 | ||||||
| 2016-09-30 | 25.15M shares 10-Q · filed 2017-11-07 | |||||||
| 2016-06-30 | 26.28M shares 10-Q · filed 2017-08-07 | |||||||
| 2016-03-31 | 26.94M shares 10-Q · filed 2017-05-08 | |||||||
| 2015-12-31 | 27.73M shares 10-K · filed 2018-03-12 | |||||||
| 2015-09-30 | 28.12M shares 10-Q · filed 2016-11-10 | |||||||
| 2015-06-30 | 26.86M shares 10-Q · filed 2015-09-10 | 26.86M shares 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | 31.87M shares 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | 6.99M shares 10-K · filed 2017-03-15 | |||||||
| 2014-09-30 | 25.30M shares 10-Q · filed 2015-11-12 | |||||||
| 2014-06-30 | 25.89M shares 10-Q · filed 2015-09-10 | 25.89M shares 10-Q · filed 2015-09-10 | ||||||
| 2013-12-31 | 9.75M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |